Naveen Pemmaraju, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss the treatment of patients with myelofibrosis, focusing on diagnostic practices, supportive care, therapies, and adverse event management.
EP. 1: Patient Diagnostic Workup Practices
Naveen Pemmaraju, MD, joins Rohit Gosain, MD, and Rahul Gosain, MD, to discuss diagnostic practices and prognostic factors for patients with myelofibrosis.
EP. 2: Supportive Care in Myelofibrosis
A hematology specialist provides clinical insights on supportive care practices for patients with myelofibrosis.
EP. 3: JAK Inhibitors in Myelofibrosis
Naveen Pemmaraju, MD, gives a comprehensive overview of JAK inhibitors available for the treatment of patients with myelofibrosis.
EP. 4: Managing Anemia and Splenomegaly in Myelofibrosis
An expert on myelofibrosis discusses anemia and splenomegaly management practices for patients with myelofibrosis.
EP. 5: Adverse Effects Associated With JAK Inhibitors in Myelofibrosis
Naveen Pemmaraju, MD, discusses adverse effects associated with JAK inhibitors in the treatment of myelofibrosis, and the Oncology Brothers recap the entire discussion.